OF THE
TIMES
There follows a guest post by 'Amanuensis', an ex-academic and senior Government researcher/scientist with experience in the field, who has undertaken a re-analysis of ONS data on deaths by vaccination status and concluded that vaccine effectiveness against death has been significantly overestimated owing to a failure to take into account the delay between infection and death. His analysis also uncovers an alarming spike in Covid deaths following vaccination during a Covid surge which, he says, needs urgent investigation. This post is also available on his Substack page.Recently a blog post was brought to my attention. This was a very interesting piece of work that is directly related to a previous post of mine analysing the deaths by vaccination status figures published by the Office for National Statistics.

A regional director who was employed at the research organisation Ventavia Research Group has told the BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer's pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided the BMJ with dozens of internal company documents, photos, audio recordings, and emails.Another Ventavia employee said of the data the company generated for the Pfizer trial:
"I don't think it was good clean data. It's a crazy mess."The six-month trial results for the Pfizer vaccine have now been published in the New England Journal of Medicine. These findings, the researchers note, "contributed to the full approval of BNT162b2 [the Pfizer vaccine] in the United States". A close inspection of the study, however, reveals a number of problems that raise serious questions about the reliability of its findings, as well as about the safety of the vaccine.
Comment: Also see: